Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Accounting Officer sold 12,300 shares at $30.20 ($371,504)
  6. 4 Open-market sale Director sold 77,400 shares at $30.24 ($2,340,646)
  7. 4 Open-market sale Exec. VP, European Commercial sold 115,468 shares at $28.68 ($3,311,126)
  8. 4 Open-market sale Sabag Mark sold 216,892 shares at an average $28.73 ($6,230,754)
  9. 4 Exercise or conversion Director acquired 4,804 shares (option exercise)
  10. 4 Open-market sale Director sold 50,000 shares at $26.03 ($1,301,505)
  11. 4 Planned sale EVP, Head of U.S. Commercial sold 28,229 shares at $24.78 ($699,523)
  12. 4 Open-market sale EVP, Head of U.S. Commercial sold 30,000 shares at $25.11 ($753,321)
  13. 4 Open-market sale Director sold 200,000 shares at $24.11 ($4,821,880)
  14. 4 Open-market sale Chief Accounting Officer sold 12,300 shares at $24.44 ($300,564)
  15. 4 Open-market buy EVP, Chief Legal Officer bought 1,113 shares at $18.86 ($20,988)
  16. 4 Open-market sale Jover Placid sold 6,053 shares at $15.16 ($91,748)
  17. 4 Planned sale Hughes Eric A sold 52,742 shares at $15.16 ($799,437)
  18. 4 Planned sale EVP, Chief Financial Officer sold 55,775 shares at $17.08 ($952,464)
  19. 4 Exercise or conversion Director acquired 9,632 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 9,632 shares (option exercise)

Page 5 of 34 · 666 filings